CIA
CIA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$281K
Insider Sales
0
$0
Total Volume
$281K
1 transactions
Net Activity
+$281K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
CIA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 50%.
Multiple Insiders
2 Insiders
$281K total
Over the last 90 days, corporate insiders at CIA (CIA) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $281K.
The net insider activity for CIA shows a net buying bias of $281K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Multiple Insiders (2 Insiders), who traded 72.0K shares valued at $281K on Aug 31, 2026.
Quick Actions
Related News & Analyst Reports
Read original insights and educational research covering CIA and the Unknown sector.
The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop
An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.
Tracking Insider Activity in Biotech: High Stakes and Hidden Signals
Biotech insiders possess unique asymmetric information, clinical results, FDA feedback, partnership negotiations. This guide explains how to track Form 4 activity at pre-commercial biotechs, what position sizes matter, and how to avoid false signals near data events.
Post-Crisis Regulations: How the Dodd-Frank Act Changed SEC Filings
The Dodd-Frank Act of 2010 reshaped SEC disclosure requirements, whistleblower incentives, and executive compensation reporting. This analysis tracks how the post-crisis regulatory shift altered insider trading patterns measured on Form 4.
Evaluating Insider Buying in Distressed Debt and Turnaround Situations
When a company is in financial distress, standard valuation metrics break down. This guide explains how to evaluate insider buying signals in turnaround and distressed scenarios — including what makes them more or less credible, which insiders to watch, and how to size positions in high-risk situations.
How CFOs Trade vs. CEOs: A Data-Driven Analysis of Who Reads Markets Better
Decades of academic research consistently shows that CFOs are more accurate insiders than CEOs when it comes to stock purchases. This analysis explains why — covering the informational advantages of the CFO role, how their trading patterns differ from CEOs, and what specific CFO buying patterns investors should watch for.
Understanding Indirect Beneficial Ownership: Trusts, LLCs, and Spouses
Executives often hold stock indirectly through family limited partnerships, trusts, and spousal accounts. This guide decodes the Indirect ownership column in Form 4 filings and explains what different beneficial ownership structures imply for interpreting insider signals.
FAQs About CIA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CIA.